ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716679; 2) Community: the network communities that were significantly associated with the response to NSC 716679; 3) Molecule: the relationships between components within communities and NSC 716679; 4) MDR: the compounds that were significantly associated with the NSC 716679.

NSC Compound Enrichment Correlation
NSC 732122 2-[3-(Benzothiazol-2-ylsulfanyl)-3-(4-methoxy-phenyl)-allyli dene]-malononitrile 0.0119653763676522 0.34555522
NSC 733901 Null 0.0119653763676522 0.0643711
NSC 740268 Indenoisoquinoline derivative 0.0119653763676522 0.33177311
NSC 751382 N-(3-((2,5-dimethylbenzyl)oxy)-4-(N-methylmethylsulfonamido)phenyl)-2,3-dihydro-1H-indene-5-carboxamide 0.0119653763676522 0.38999104
NSC 763621 (Z)-3-((2-(4-(trifluoromethyl)phenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0119653763676522 0.38190965
NSC 102225 Null 0.0131142867047949 0.4224561
NSC 105132 Deoxycamptothecin 0.0131142867047949 0.27905705
NSC 134723 K 31 0.0131142867047949 0.21867222
NSC 149765 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) 0.0131142867047949 0.15164319
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.0131142867047949 0.27143162
Total:116  Current:47    [First] [Prev] [Next] [Last]